Literature DB >> 29891876

A three-generation family with metaphyseal dysplasia, maxillary hypoplasia and brachydactyly (MDMHB) due to intragenic RUNX2 duplication.

Amina Al-Yassin1, Alistair D Calder2, Mike Harrison3, Tracy Lester4, Helen Lord4, Michael Oldridge4, Sophie Watkins3, Richard Keen5, Emma L Wakeling6.   

Abstract

Metaphyseal dysplasia with maxillary hypoplasia and brachydactyly (MDMHB) is an autosomal-dominant skeletal dysplasia characterised by metaphyseal flaring of the long bones, enlargement of the medial halves of the clavicles, maxillary hypoplasia, brachydactyly, dental anomalies and mild osteoporosis. To date, only one large French Canadian family and a Finnish woman have been reported with the condition. In both, intragenic duplication encompassing exons 3-5 of the RUNX2 gene was identified. We describe a new, three-generation family with clinical features of MDMHB and an intragenic tandem duplication of RUNX2 exons 3-6. Dental problems were the primary presenting feature in all four affected individuals. We compare the features in our family to those previously reported in MDMHB, review the natural history of this condition and highlight the importance of considering an underlying skeletal dysplasia in patients presenting with significant dental problems and other suggestive features, including disproportionate short stature and/or digital anomalies.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29891876      PMCID: PMC6117264          DOI: 10.1038/s41431-018-0166-7

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  15 in total

Review 1.  Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression.

Authors:  Gary S Stein; Jane B Lian; Andre J van Wijnen; Janet L Stein; Martin Montecino; Amjad Javed; Sayyed K Zaidi; Daniel W Young; Je-Yong Choi; Shirwin M Pockwinse
Journal:  Oncogene       Date:  2004-05-24       Impact factor: 9.867

2.  A new form of skeletal dysplasia with amelogenesis imperfecta and platyspondyly.

Authors:  A Verloes; P Jamblin; L Koulischer; J P Bourguignon
Journal:  Clin Genet       Date:  1996-01       Impact factor: 4.438

3.  Identification of a mutation in DLX3 associated with tricho-dento-osseous (TDO) syndrome.

Authors:  J A Price; D W Bowden; J T Wright; M J Pettenati; T C Hart
Journal:  Hum Mol Genet       Date:  1998-03       Impact factor: 6.150

4.  Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia.

Authors:  S Mundlos; F Otto; C Mundlos; J B Mulliken; A S Aylsworth; S Albright; D Lindhout; W G Cole; W Henn; J H Knoll; M J Owen; R Mertelsmann; B U Zabel; B R Olsen
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

5.  Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts.

Authors:  T Komori; H Yagi; S Nomura; A Yamaguchi; K Sasaki; K Deguchi; Y Shimizu; R T Bronson; Y H Gao; M Inada; M Sato; R Okamoto; Y Kitamura; S Yoshiki; T Kishimoto
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

6.  Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development.

Authors:  F Otto; A P Thornell; T Crompton; A Denzel; K C Gilmour; I R Rosewell; G W Stamp; R S Beddington; S Mundlos; B R Olsen; P B Selby; M J Owen
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

7.  A novel heterozygous deletion in the EVC2 gene causes Weyers acrofacial dysostosis.

Authors:  Xiaoqian Ye; Guangtai Song; Mingwen Fan; Lisong Shi; Ethylin Wang Jabs; Shangzhi Huang; Ruiqiang Guo; Zhuan Bian
Journal:  Hum Genet       Date:  2006-01-11       Impact factor: 4.132

Review 8.  Making a tooth: growth factors, transcription factors, and stem cells.

Authors:  Yan Ding Zhang; Zhi Chen; Yi Qiang Song; Chao Liu; Yi Ping Chen
Journal:  Cell Res       Date:  2005-05       Impact factor: 25.617

9.  Metaphyseal dysplasia with maxillary hypoplasia and brachydactyly.

Authors:  F Halal; J L Picard; D Raymond-Tremblay; P de Bosset
Journal:  Am J Med Genet       Date:  1982-09

10.  Copy number variation analysis in single-suture craniosynostosis: multiple rare variants including RUNX2 duplication in two cousins with metopic craniosynostosis.

Authors:  Heather C Mefford; Neil Shafer; Francesca Antonacci; Jesse M Tsai; Sarah S Park; Anne V Hing; Mark J Rieder; Matthew D Smyth; Matthew L Speltz; Evan E Eichler; Michael L Cunningham
Journal:  Am J Med Genet A       Date:  2010-09       Impact factor: 2.802

View more
  5 in total

1.  Brd4 is required for chondrocyte differentiation and endochondral ossification.

Authors:  Christopher R Paradise; M Lizeth Galvan; Oksana Pichurin; Sofia Jerez; Eva Kubrova; S Sharare Dehghani; Margarita E Carrasco; Roman Thaler; A Noelle Larson; Andre J van Wijnen; Amel Dudakovic
Journal:  Bone       Date:  2021-10-23       Impact factor: 4.626

Review 2.  Signaling Pathways in Bone Development and Their Related Skeletal Dysplasia.

Authors:  Alessandra Guasto; Valérie Cormier-Daire
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

3.  p.E95K mutation in Indian hedgehog causing brachydactyly type A1 impairs IHH/Gli1 downstream transcriptional regulation.

Authors:  Lu Shen; Gang Ma; Ye Shi; Yunfeng Ruan; Xuhan Yang; Xi Wu; Yuyu Xiong; Chunling Wan; Chao Yang; Lei Cai; Likuan Xiong; Xueli Gong; Lin He; Shengying Qin
Journal:  BMC Genet       Date:  2019-01-16       Impact factor: 2.797

4.  Altered microRNAs in C3H10T1/2 cells induced by p.E95K mutant IHH signaling.

Authors:  Wei Zhou; Luan Chen; Hao Wu; Ting Wang; Gang Ma; Baocheng Wang; Cong Wang; Na Zhang; Yingtian Zhang; Lin He; Shengying Qin; Xiaofang Sun; Hai Zhang; Lu Shen
Journal:  Hereditas       Date:  2021-12-18       Impact factor: 3.271

5.  Cleidocranial dysplasia and novel RUNX2 variants: dental, craniofacial, and osseous manifestations.

Authors:  Sermporn Thaweesapphithak; Jirawat Saengsin; Wuttichart Kamolvisit; Thanakorn Theerapanon; Thantrira Porntaveetus; Vorasuk Shotelersuk
Journal:  J Appl Oral Sci       Date:  2022-06-06       Impact factor: 3.144

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.